|
1）Carroll JD, Saver JL, Thaler DE, et al; RESPECT Investigators. Closure of patent foramen ovale versus medical therapy after cryptogenic stroke. N Engl J Med. 2013; 368: 1092-100
|
|
|
|
2）原 英彦，河村朗夫，白井伸一，他．経皮的心房中隔欠損閉鎖術の進歩: 日本心血管インターベンション治療学会多施設共同レジストリーからの検討．循環器専門医．2013; 21: 256-61
|
|
|
|
|
3）Hara H, Virmani R, Ladich E, et al. Patent foramen ovale: current pathology, pathophysiology, and clinical status. J Am Coll Cardiol. 2005; 46: 1768-76
|
|
|
|
|
|
4）Dowson A, Mullen MJ, Peatfield R, et al. Migraine Intervention With STARFlex Technology (MIST) trial: a prospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache. Circulation. 2008; 117: 1397-404
|
|
|
|
|
|
5）Furlan AJ, Reisman M, Massaro J, et al; CLOSURE I Investigators. Closure or medical therapy for cryptogenic stroke with patent foramen ovale. N Engl J Med. 2012; 366: 991-9
|
|
|
|
|
|
6）Hara H, Virmani R, Ladich E, et al. Patent foramen ovale: standards for a preclinical model of prevalence, structure, and histopathologic comparability to human hearts. Catheter Cardiovasc Interv. 2007; 69: 266-73
|
|
|
|
|
|
7）Ueno Y, Iguchi Y, Inoue T, et al. Paradoxical brain embolism may not be uncommon-prospective study in acute ischemic stroke. J Neurol. 2007; 254: 763-6
|
|
|
|
|
|
8）Alsheikh-Ali AA, Thaler DE, Kent DM. Patent foramen ovale in cryptogenic stroke: incidental or pathogenic? Stroke. 2009; 40: 2349-55
|
|
|
|
|
|
9）Blanche C, Noble S, Roffi M, et al. Platypnea-orthodeoxia syndrome in the elderly treated by percutaneous patent foramen ovale closure: A case series and literature review. Eur J Intern Med. 2013 Sep 2. pii: S0953-6205(13)00907-2
|
|
|
|
|
|
10）Mas JL, Arquizan C, Lamy C, et al. Patent Foramen Ovale and Atrial Septal Aneurysm Study Group. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med. 2001; 345: 1740-6
|
|
|
|
|
|
11）Mullen MJ, Hildick-Smith D, De Giovanni JV, et al. BioSTAR Evaluation STudy (BEST): a prospective, multicenter, phase I clinical trial to evaluate the feasibility, efficacy, and safety of the BioSTAR bioabsorbable septal repair implant for the closure of atrial-level shunts. Circulation. 2006; 114: 1962-7
|
|
|
|
|
|
12）Hara H, Jones TK, Ladich ER, et al. Patent foramen ovale closure by radiofrequency thermal coaptation: first experience in the porcine model and healing mechanisms over time. Circulation. 2007; 116: 648-53
|
|
|
|
|
|
13）Sievert H, Wunderlich N, Reiffenstein I, et al. Initial clinical experience with the Coherex FlatStent™ and FlatStent™ EF PFO closure system for in-tunnel PFO closure: Results of the Coherex-EU study. Catheter Cardiovasc Interv. 2012 Jul 19. doi: 10.1002/ccd.24565
|
|
|
|
|